Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.81 |
| ▸ | ESR1 | P03372 | 4/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.59 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.55 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.53 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | BACE1 | P56817 | 2/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HTR3A | P46098 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
| ▸ | TACR2 | P21452 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosol SCHEMBL43838 | 0.90 | CA2 (1.00) | CA2ESR1ESR2ALDH1A1ADRA2A | |
| Tyrosol SCHEMBL28157257 | 0.87 | CA2 (0.94) | CA2ESR1ESR2ALDH1A1ADRA2A | |
| Tyrosol SCHEMBL27940319 | 0.87 | CA2 (0.94) | CA2ESR1ESR2ALDH1A1ADRA2A | |
| Tyrosol SCHEMBL28609607 | 0.87 | CA2 (0.94) | CA2ESR1ESR2ALDH1A1ADRA2A | |
| SCHEMBL10458523 | 0.83 | CA2 (0.85) | CA2ESR1ESR2ALDH1A1ADRA2A | |
| SCHEMBL6817399 | 0.81 | CA2 (0.58) | CA2ESR1ESR2CALM1CYP4F2 | |
| Tyrosol SCHEMBL11040022 | 0.80 | CA2 (0.71) | CA2ESR1ESR2CYP4F2CYP4A11 | |
| Methoxymethane SCHEMBL28116150 | 0.79 | ESR1 (0.76) | CA2ESR1ESR2CALM1ALDH1A1 | |
| SCHEMBL40656 | 0.79 | CA2 (0.77) | CA2ESR1ESR2CYP4F2CYP4A11 | |
| SCHEMBL28001754 | 0.79 | CA2 (0.68) | CA2ESR1ESR2CALM1CYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2315739-B1 | NEW PROPANOATES AND PROCESSES FOR PREPARING THE SAME | DUPONT ELECTRONIC POLYMERS L P (US) | 2014-11-12 | — | — | EP | claimed |
| US-8163464-B2 | Propanoates and processes for preparing the same | Du Pont Electronic Polymers L.P. (US) | 2012-04-24 | — | — | US | claimed |
| JP-2012500846-A | — | — | 2012-01-12 | — | — | JP | claimed |
| EP-2336216-A1 | Derivatized polyhydroxystyrenes with a novolak type structure and processes for preparing the same | DuPont Electronic Polymers L.P. (US) | 2011-06-22 | — | — | EP | claimed |
| EP-2315739-A1 | NEW PROPANOATES AND PROCESSES FOR PREPARING THE SAME | DuPont Electronic Polymers L.P. (US) | 2011-05-04 | — | — | EP | claimed |
| JP-4629097-B2 | — | — | 2011-02-09 | — | — | JP | claimed |
| US-20100105785-A1 | Derivatized polyhydroxystyrenes (DPHS) with a novolak type structure and blocked DPHS (BDPHS) and processes for preparing the same | SHEEHAN MICHAEL T | 2010-04-29 | — | — | US | claimed |
| US-7678945-B2 | Derivatized polyhydroxystyrenes with a novolak type structure and processes for preparing the same | DUPONT ELECTRONIC POLYMERS L.P. (US) | 2010-03-16 | — | — | US | claimed |
| WO-2010024841-A1 | NEW PROPANOATES AND PROCESSES FOR PREPARING THE SAME | DUPONT ELECTRONIC POLYMERS L.P. (US) | 2010-03-04 | — | — | WO | claimed |
| US-20100047714-A1 | New propanoates and processes for preparing the same | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2010-02-25 | — | — | US | claimed |
| US-20080214874-A1 | Derivatized polyhydroxystyrenes with a novolak type structure and processes for preparing the same | SHEEHAN MICHAEL T | 2008-09-04 | — | — | US | claimed |
| US-7371800-B2 | Derivatized novolak polyhydroxystyrene from hydroxyphenylmethylcarbinol | DUPONT ELECTRONIC POLYMERS L.P. (US) | 2008-05-13 | — | — | US | claimed |
| EP-1756191-A1 | DERIVATIZED POLYHYDROXYSTYRENES WITH A NOVOLAK TYPE STRUCTURE AND PROCESSES FOR PREPARING THE SAME | Dupont Electronic Polymers L.P. (US) | 2007-02-28 | — | — | EP | claimed |
| WO-2006052380-A1 | DERIVATIZED POLYHYDROXYSTRYRENE (DPHS)WITH A NOVOLAK TYPE STRUCTURE AND BLOCKED DPHS (BDPHS) AND PROCESSES FOR PREPARING THE SAME | DUPONT ELECTRONIC POLYMERS L.P. (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060099531-A1 | Derivatized polyhydroxystyrenes (DPHS) with a novolak type structure and blocked DPHS (BDPHS) and processes for preparing the same | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2006-05-11 | — | — | US | claimed |
| WO-2005113634-A1 | DERIVATIZED POLYHYDROXYSTYRENES WITH A NOVOLAK TYPE STRUCTURE AND PROCESSES FOR PREPARING THE SAME | DUPONT ELECTRONIC POLYMERS L.P. (US) | 2005-12-01 | — | — | WO | claimed |
| US-20050250042-A1 | Derivatized polyhydroxystyrenes with a novolak type structure and processes for preparing the same | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2005-11-10 | — | — | US | claimed |
| US-20230374213-A1 | PROCESS FOR PREPARING BRANCHED PHENOLIC NOVOLAK | ADVANCED POLYMER COATINGS, INC. (US) | 2023-11-23 | — | — | US | disclosed |
| US-5565544-A | POLYMERIZING A MIXTURE OF CARBOXYLIC ACID AND AT LEAST ONE SUSTITUTED PHENYL CARBINOL | HOECHST CELANESE CORPORATION (US) | 1996-10-15 | — | — | US | disclosed |
| US-5554719-A | Polyhydroxystyrene with a novolak type structure | HOECHST CELANESE CORPORATION (US) | 1996-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100047714-A1 | New propanoates and processes for preparing the same | HPD, HMBS, LDHB | CA2 1637/4885ESR1 1760/4885ESR2 2692/4885 |
| US-20080214874-A1 | Derivatized polyhydroxystyrenes with a novolak type structure and processes for preparing the same | VRK1, VRK2, CHKB | CA2 2666/4885ESR1 1023/4885ESR2 997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.